Oculis Holding AG (OCS)
8.72
+0.16
(+1.87%)
USD |
NASDAQ |
Oct 06, 16:00
8.72
0.00 (0.00%)
After-Hours: 20:00
Oculis EPS Diluted (Quarterly) : -0.2059 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2059 |
| March 31, 2026 | -0.625 |
| December 31, 2025 | -0.5255 |
| September 30, 2025 | -0.4023 |
| June 30, 2025 | -0.5869 |
| March 31, 2025 | -0.7655 |
| December 31, 2024 | -0.7636 |
| September 30, 2024 | -0.5574 |
| June 30, 2024 | -0.5684 |
| March 31, 2024 | -0.5026 |
| December 31, 2023 | -0.3844 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.5425 |
| June 30, 2023 | -0.4268 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.0275 |
| September 30, 2021 | 0.0733 |
| June 30, 2021 | 0.0289 |
| March 31, 2021 | 0.016 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 1.706 |
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | -2.160 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.61M |
| Total Expenses (Quarterly) | 12.61M |
| Enterprise Value | 248.53M |
| Earnings Yield | -20.17% |
| Normalized Earnings Yield | -20.80 |